Trials / Completed
CompletedNCT06697899
TGRX-678 Phase I Oral Pharmacokinetic Study
Food Effect on Pharmacokinetic Profile for TGRX-678 Tablet in Chinese Healthy Subject With Single Oral Administration
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 76 (actual)
- Sponsor
- Shenzhen TargetRx Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
A study evaluating the effects of food intake on the pharmacokinetic (PK) profiles of TGRX-678
Detailed description
This study is designed as single-center, single-dose, randomized, open-label and parallel-comparison to evaluate food effect on PK profile of TGRX-678 in healthy subjects. Safety and tolerability of the drug is also evaluated during study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TGRX-678 | All participants are given TGRX-678 orally at 240 mg |
Timeline
- Start date
- 2024-11-24
- Primary completion
- 2025-01-06
- Completion
- 2025-02-20
- First posted
- 2024-11-20
- Last updated
- 2025-05-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06697899. Inclusion in this directory is not an endorsement.